1. Discovery and Characterization of Selective, First-in-Class Inhibitors of Citron Kinase
   Joshua J. Maw et al, 2024, Journal of Medicinal Chemistry CrossRef
2. Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients
   Alexander Fichte et al, 2022, Life CrossRef